<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35953727</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0428</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Diabetologia</Title><ISOAbbreviation>Diabetologia</ISOAbbreviation></Journal><ArticleTitle>Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study.</ArticleTitle><Pagination><StartPage>2108</StartPage><EndPage>2120</EndPage><MedlinePgn>2108-2120</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00125-022-05779-2</ELocationID><Abstract><AbstractText Label="AIMS/HYPOTHESIS">Enterovirus (EV) infection of pancreatic islet cells is one possible factor contributing to type 1 diabetes development. We have reported the presence of EV genome by PCR and of EV proteins by immunohistochemistry in pancreatic sections. Here we explore multiple human virus species in the Diabetes Virus Detection (DiViD) study cases using innovative methods, including virus passage in cell cultures.</AbstractText><AbstractText Label="METHODS">Six recent-onset type 1 diabetes patients (age 24-35) were included in the DiViD study. Minimal pancreatic tail resection was performed under sterile conditions. Eleven live cases (age 43-83) of pancreatic carcinoma without diabetes served as control cases. In the present study, we used EV detection methods that combine virus growth in cell culture, gene amplification and detection of virus-coded proteins by immunofluorescence. Pancreas homogenates in cell culture medium were incubated with EV-susceptible cell lines for 3 days. Two to three blind passages were performed. DNA and RNA were extracted from both pancreas tissue and cell cultures. Real-time PCR was used for detecting 20 different viral agents other than EVs (six herpesviruses, human polyomavirus [BK virus and JC virus], parvovirus B19, hepatitis B virus, hepatitis C virus, hepatitis A virus, mumps, rubella, influenza A/B, parainfluenza 1-4, respiratory syncytial virus, astrovirus, norovirus, rotavirus). EV genomes were detected by endpoint PCR using five primer pairs targeting the partially conserved 5' untranslated region genome region of the A, B, C and D species. Amplicons were sequenced. The expression of EV capsid proteins was evaluated in cultured cells using a panel of EV antibodies.</AbstractText><AbstractText Label="RESULTS">Samples from six of six individuals with type 1 diabetes (cases) and two of 11 individuals without diabetes (control cases) contained EV genomes (p&lt;0.05). In contrast, genomes of 20 human viruses other than EVs could be detected only once in an individual with diabetes (Epstein-Barr virus) and once in an individual without diabetes (parvovirus B19). EV detection was confirmed by immunofluorescence of cultured cells incubated with pancreatic extracts: viral antigens were expressed in the cytoplasm of approximately 1% of cells. Notably, infection could be transmitted from EV-positive cell cultures to uninfected cell cultures using supernatants filtered through 100 nm membranes, indicating that infectious agents of less than 100 nm were present in pancreases. Due to the slow progression of infection in EV-carrying cell cultures, cytopathic effects were not observed by standard microscopy but were recognised by measuring cell viability. Sequences of 5' untranslated region amplicons were compatible with EVs of the B, A and C species. Compared with control cell cultures exposed to EV-negative pancreatic extracts, EV-carrying cell cultures produced significantly higher levels of IL-6, IL-8 and monocyte chemoattractant protein-1 (MCP1).</AbstractText><AbstractText Label="CONCLUSIONS/INTERPRETATION">Sensitive assays confirm that the pancreases of all DiViD cases contain EVs but no other viruses. Analogous EV strains have been found in pancreases of two of 11 individuals without diabetes. The detected EV strains can be passaged in series from one cell culture to another in the form of poorly replicating live viruses encoding antigenic proteins recognised by multiple EV-specific antibodies. Thus, the early phase of type 1 diabetes is associated with a low-grade infection by EVs, but not by other viral agents.</AbstractText><CopyrightInformation>© 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krogvold</LastName><ForeName>Lars</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1057-7095</Identifier><AffiliationInfo><Affiliation>Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway. lars.krogvold@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Oslo, Norway. lars.krogvold@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genoni</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9848-2981</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puggioni</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campani</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5987-734X</Identifier><AffiliationInfo><Affiliation>Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-1160-6062</Identifier><AffiliationInfo><Affiliation>Islet Biology Group (IBEx), Exeter Centre of Excellence in Diabetes (EXCEED), University of Exeter College of Medicine and Health, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flaxman</LastName><ForeName>Christine S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Islet Biology Group (IBEx), Exeter Centre of Excellence in Diabetes (EXCEED), University of Exeter College of Medicine and Health, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwin</LastName><ForeName>Bjørn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department for HPB Surgery, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buanes</LastName><ForeName>Trond</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department for HPB Surgery, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahl-Jørgensen</LastName><ForeName>Knut</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6952-9899</Identifier><AffiliationInfo><Affiliation>Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toniolo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3008-2126</Identifier><AffiliationInfo><Affiliation>Global Virus Network, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/P010695/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Diabetologia</MedlineTA><NlmUniqueID>0006777</NlmUniqueID><ISSNLinking>0012-186X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020121">5' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010184">Pancreatic Extracts</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020121" MajorTopicYN="N">5' Untranslated Regions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020031" MajorTopicYN="Y">Epstein-Barr Virus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010184" MajorTopicYN="N">Pancreatic Extracts</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biopsy</Keyword><Keyword MajorTopicYN="N">Cell culture</Keyword><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">Gene amplification</Keyword><Keyword MajorTopicYN="N">Immunofluorescence</Keyword><Keyword MajorTopicYN="N">Pancreas</Keyword><Keyword MajorTopicYN="N">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35953727</ArticleId><ArticleId IdType="pmc">PMC9630231</ArticleId><ArticleId IdType="doi">10.1007/s00125-022-05779-2</ArticleId><ArticleId IdType="pii">10.1007/s00125-022-05779-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ilonen J, Lempainen J, Veijola R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. 2019;15(11):635–650. doi: 10.1038/s41574-019-0254-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-019-0254-y</ArticleId><ArticleId IdType="pubmed">31534209</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia. 2013;56(1):185–193. doi: 10.1007/s00125-012-2745-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-012-2745-4</ArticleId><ArticleId IdType="pubmed">23064357</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan NG, Richardson SJ. Fifty years of pancreatic islet pathology in human type 1 diabetes: insights gained and progress made. Diabetologia. 2018;61(12):2499–2506. doi: 10.1007/s00125-018-4731-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-018-4731-y</ArticleId><ArticleId IdType="pmc">PMC6223849</ArticleId><ArticleId IdType="pubmed">30255378</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Edwin B, Buanes T, et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes. 2015;64(5):1682–1687. doi: 10.2337/db14-1370.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1370</ArticleId><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg M, Krogvold L, Kuric E, Dahl-Jorgensen K, Skog O. Expression of interferon-stimulated genes in insulitic pancreatic islets of patients recently diagnosed with type 1 diabetes. Diabetes. 2016;65:3104–3110. doi: 10.2337/db16-0616.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db16-0616</ArticleId><ArticleId IdType="pubmed">27422384</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, Rodriguez-Calvo T, Gerling IC, et al. Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes. Diabetologia. 2016;59:2448–2458. doi: 10.1007/s00125-016-4067-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-016-4067-4</ArticleId><ArticleId IdType="pmc">PMC5042874</ArticleId><ArticleId IdType="pubmed">27506584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuric E, Seiron P, Krogvold L, et al. Demonstration of tissue resident memory CD8 T cells in insulitic lesions in adult patients with recent-onset type 1 diabetes. Am J Pathol. 2017;187:581–588. doi: 10.1016/j.ajpath.2016.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2016.11.002</ArticleId><ArticleId IdType="pubmed">28212742</ArticleId></ArticleIdList></Reference><Reference><Citation>Sioofy-Khojine AB, Oikarinen S, Honkanen H, et al. Molecular epidemiology of enteroviruses in young children at increased risk of type 1 diabetes. PLoS One. 2018;13(9):e0201959. doi: 10.1371/journal.pone.0201959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0201959</ArticleId><ArticleId IdType="pmc">PMC6128458</ArticleId><ArticleId IdType="pubmed">30192755</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkanen H, Oikarinen S, Nurminen N, et al. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia. 2017;60(3):424–431. doi: 10.1007/s00125-016-4177-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-016-4177-z</ArticleId><ArticleId IdType="pubmed">28070615</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik K, Lynch KF, Wong MC, et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat Med. 2019;25(12):1865–1872. doi: 10.1038/s41591-019-0667-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0667-0</ArticleId><ArticleId IdType="pmc">PMC6898786</ArticleId><ArticleId IdType="pubmed">31792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang JW, Holmes CW. Acute and chronic disease caused by enteroviruses. Virulence. 2017;8(7):1062–1065. doi: 10.1080/21505594.2017.1308620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2017.1308620</ArticleId><ArticleId IdType="pmc">PMC5711444</ArticleId><ArticleId IdType="pubmed">28362547</ArticleId></ArticleIdList></Reference><Reference><Citation>Genoni A, Canducci F, Rossi A, et al. Revealing enterovirus infection in chronic human disorders: an integrated diagnostic approach. Sci Rep. 2017;7(1):5013. doi: 10.1038/s41598-017-04993-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04993-y</ArticleId><ArticleId IdType="pmc">PMC5504018</ArticleId><ArticleId IdType="pubmed">28694527</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes AC, Semler BL. Picornaviruses and RNA metabolism: local and global effects of infection. J Virol. 2019;93(21):e02088. doi: 10.1128/jvi.02088-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02088-17</ArticleId><ArticleId IdType="pmc">PMC6803262</ArticleId><ArticleId IdType="pubmed">31413128</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Vomund AN, Peterson OJ, Chervonsky AV, Lichti CF, Unanue ER. The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides. Nat Immunol. 2020;21(4):455–463. doi: 10.1038/s41590-020-0623-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0623-7</ArticleId><ArticleId IdType="pmc">PMC7117798</ArticleId><ArticleId IdType="pubmed">32152506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyöty H. Viruses in type 1 diabetes. Pediatr Diabetes. 2016;17(Suppl 22):56–64. doi: 10.1111/pedi.12370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12370</ArticleId><ArticleId IdType="pubmed">27411438</ArticleId></ArticleIdList></Reference><Reference><Citation>Op de Beeck A, Eizirik DL. Viral infections in type 1 diabetes mellitus--why the β cells? Nat Rev Endocrinol. 2016;12(5):263–273. doi: 10.1038/nrendo.2016.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2016.30</ArticleId><ArticleId IdType="pmc">PMC5348720</ArticleId><ArticleId IdType="pubmed">27020257</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison LC, Perrett KP, Jachno K, Nolan TM, Honeyman MC. Does rotavirus turn on type 1 diabetes? PLoS Pathog. 2019;15(10):e1007965. doi: 10.1371/journal.ppat.1007965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007965</ArticleId><ArticleId IdType="pmc">PMC6786515</ArticleId><ArticleId IdType="pubmed">31600345</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen DW, Kim KW, Rawlinson WD, Craig ME. Maternal virus infections in pregnancy and type 1 diabetes in their offspring: Systematic review and meta-analysis of observational studies. Rev Med Virol. 2018;28(3):e1974. doi: 10.1002/rmv.1974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1974</ArticleId><ArticleId IdType="pubmed">29569297</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohara N, Kaneko M, Kuwano H, et al. Fulminant type 1 diabetes mellitus and fulminant viral myocarditis. A case report and literature review. Int Heart J. 2015;56(2):239–244. doi: 10.1536/ihj.14-250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.14-250</ArticleId><ArticleId IdType="pubmed">25740579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayakawa T, Nakano Y, Hayakawa K, et al. Fulminant type 1 diabetes mellitus associated with Coxsackievirus type B1 infection during pregnancy: a case report. J Med Case Rep. 2019;13(1):186. doi: 10.1186/s13256-019-2130-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-019-2130-8</ArticleId><ArticleId IdType="pmc">PMC6582524</ArticleId><ArticleId IdType="pubmed">31215492</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeno A, Kanazawa I, Morita M, et al. A case report of fulminant type 1 diabetes mellitus associated with drug-induced hypersensitivity syndrome in an elderly patient with coxsackie B4 virus infection and human leukocyte antigen-A24 haplotype. Endocr J. 2018;65(1):129–132. doi: 10.1507/endocrj.EJ17-0249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ17-0249</ArticleId><ArticleId IdType="pubmed">28966225</ArticleId></ArticleIdList></Reference><Reference><Citation>Capua I, Mercalli A, Romero-Tejeda A, et al. Study of 2009 H1N1 pandemic influenza virus as a possible causative agent of diabetes. J Clin Endocrinol Metab. 2018;103(12):4343–4356. doi: 10.1210/jc.2018-00862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2018-00862</ArticleId><ArticleId IdType="pubmed">30203067</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad HA, Patterson CC, Cardwell CR. Systematic review and meta-analysis of the association between mumps during childhood and risk of type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2016;29(10):1123–1128. doi: 10.1515/jpem-2016-0148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jpem-2016-0148</ArticleId><ArticleId IdType="pubmed">27658134</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneda S, Imagawa A, Fukui K, et al. A histological study of fulminant type 1 diabetes mellitus related to human cytomegalovirus reactivation. J Clin Endocrinol Metab. 2017;102(7):2394–2400. doi: 10.1210/jc.2016-4029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2016-4029</ArticleId><ArticleId IdType="pubmed">28398495</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiya A, Ochiai H, Mizukoshi T, et al. Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein-Barr virus that developed in the course of chemotherapy of multiple myeloma. J Diabetes Investig. 2010;1(6):286–289. doi: 10.1111/j.2040-1124.2010.00061.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2040-1124.2010.00061.x</ArticleId><ArticleId IdType="pmc">PMC4014894</ArticleId><ArticleId IdType="pubmed">24843446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabouri S, Benkahla MA, Kiosses WB, et al. Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes. J Autoimmun. 2020;107:102378. doi: 10.1016/j.jaut.2019.102378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102378</ArticleId><ArticleId IdType="pmc">PMC7237334</ArticleId><ArticleId IdType="pubmed">31818546</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Ji H, Shao J, et al. Different hepatitis C virus infection statuses show a significant risk of developing type 2 diabetes mellitus: a network meta-analysis. Dig Dis Sci. 2020;65(7):1940–1950. doi: 10.1007/s10620-019-05918-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-019-05918-7</ArticleId><ArticleId IdType="pubmed">31758432</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Edwin B, Buanes T, et al. Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia. 2014;57(4):841–843. doi: 10.1007/s00125-013-3155-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-013-3155-y</ArticleId><ArticleId IdType="pubmed">24429579</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikarinen S, Krogvold L, Edwin B, et al. Characterisation of enterovirus RNA detected in the pancreas and other specimens of live patients with newly diagnosed type 1 diabetes in the DiViD study. Diabetologia. 2021;64(11):2491–2501. doi: 10.1007/s00125-021-05525-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-021-05525-0</ArticleId><ArticleId IdType="pmc">PMC8494699</ArticleId><ArticleId IdType="pubmed">34390364</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Wiberg A, Edwin B, et al. Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes. Diabetologia. 2016;59:492–501. doi: 10.1007/s00125-015-3820-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-015-3820-4</ArticleId><ArticleId IdType="pubmed">26602422</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Skog O, Sundstrom G, et al. Function of isolated pancreatic islets from patients at onset of type 1 diabetes; insulin secretion can be restored after some days in a non-diabetogenic environment in vitro. Results from the DiViD study. Diabetes. 2015;64(7):2506–2512. doi: 10.2337/db14-1911.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1911</ArticleId><ArticleId IdType="pubmed">25677915</ArticleId></ArticleIdList></Reference><Reference><Citation>Leete P, Willcox A, Krogvold L, et al. Differential insulitic profiles determine the extent of beta cell destruction and the age at onset of type 1 diabetes. Diabetes. 2016;65:1362–1369. doi: 10.2337/db15-1615.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db15-1615</ArticleId><ArticleId IdType="pubmed">26858360</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermark GT, Krogvold L, Dahl-Jørgensen K, Ludvigsson J. Islet amyloid in recent-onset type 1 diabetes-the DiViD study. Ups J Med Sci. 2017;122(3):201–203. doi: 10.1080/03009734.2017.1359219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03009734.2017.1359219</ArticleId><ArticleId IdType="pmc">PMC5649327</ArticleId><ArticleId IdType="pubmed">28814132</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccari G, Genoni A, Sansonno S, Toniolo A. Properties of two enterovirus antibodies that are utilized in diabetes research. Sci Rep. 2016;6:24757. doi: 10.1038/srep24757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24757</ArticleId><ArticleId IdType="pmc">PMC4835795</ArticleId><ArticleId IdType="pubmed">27091243</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikarinen M, Bertolet L, Toniolo A, et al. Differential detection of encapsidated versus unencapsidated enterovirus RNA in samples containing pancreatic enzymes-relevance for diabetes studies. Viruses. 2020;12(7):747. doi: 10.3390/v12070747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12070747</ArticleId><ArticleId IdType="pmc">PMC7411921</ArticleId><ArticleId IdType="pubmed">32664501</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassidy H, Schuele L, Lizarazo-Forero E, et al. Exploring a prolonged enterovirus C104 infection in a severely ill patient using nanopore sequencing. Virus Evol. 2022;8(1):veab109. doi: 10.1093/ve/veab109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab109</ArticleId><ArticleId IdType="pmc">PMC8932292</ArticleId><ArticleId IdType="pubmed">35317350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lernmark Å. Environmental factors in the etiology of type 1 diabetes, celiac disease, and narcolepsy. Pediatr Diabetes. 2016;17(Suppl 22):65–72. doi: 10.1111/pedi.12390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12390</ArticleId><ArticleId IdType="pmc">PMC5473290</ArticleId><ArticleId IdType="pubmed">27411439</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunne JL, Richardson SJ, Atkinson MA, et al. Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes. Diabetologia. 2019;62(5):744–753. doi: 10.1007/s00125-019-4811-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-019-4811-7</ArticleId><ArticleId IdType="pmc">PMC6450860</ArticleId><ArticleId IdType="pubmed">30675626</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019;11(8):762. doi: 10.3390/v11080762.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11080762</ArticleId><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammerstad SS, Tauriainen S, Hyöty H, Paulsen T, Norheim I, Dahl-Jørgensen K. Detection of enterovirus in the thyroid tissue of patients with Graves’ disease. J Med Virol. 2013;85(3):512–518. doi: 10.1002/jmv.23476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23476</ArticleId><ArticleId IdType="pubmed">23280563</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo A, Federico G, Diaz-Horta O, Maccari G, Baj A. Enteroviruses in blood. In: Taylor K, Hyöty H, Toniolo A, Zuckerman AJ, editors. Diabetes and viruses. New York: Springer; 2013. pp. 143–155.</Citation></Reference><Reference><Citation>Salvatoni A, Baj A, Bianchi G, Federico G, Colombo M, Toniolo A. Intrafamilial spread of enterovirus infections at the clinical onset of type 1 diabetes. Pediatr Diabetes. 2013;14(6):407–416. doi: 10.1111/pedi.12056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12056</ArticleId><ArticleId IdType="pubmed">23763622</ArticleId></ArticleIdList></Reference><Reference><Citation>Federico G, Genoni A, Puggioni A, et al. Vitamin D status, enterovirus infection, and type 1 diabetes in Italian children/adolescents. Pediatr Diabetes. 2018;19(5):923–929. doi: 10.1111/pedi.12673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12673</ArticleId><ArticleId IdType="pubmed">29569355</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KW, Horton JL, Pang CNI, et al. Higher abundance of enterovirus A species in the gut of children with islet autoimmunity. Sci Rep. 2019;9(1):1749. doi: 10.1038/s41598-018-38368-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-38368-8</ArticleId><ArticleId IdType="pmc">PMC6370883</ArticleId><ArticleId IdType="pubmed">30741981</ArticleId></ArticleIdList></Reference><Reference><Citation>Weider T, Genoni A, Broccolo F et al (2022) High prevalence of common human viruses in thyroid tissue. Front Endocrinol 13:938633. 10.3389/fendo.2022.938633</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9333159</ArticleId><ArticleId IdType="pubmed">35909527</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo A, Onodera T, Jordan G, Yoon JW, Notkins AL. Virus-induced diabetes mellitus. Glucose abnormalities produced in mice by the six members of the Coxsackie B virus group. Diabetes. 1982;31(6 Pt 1):496–499. doi: 10.2337/diab.31.6.496.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.31.6.496</ArticleId><ArticleId IdType="pubmed">6759266</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyöty H, Leon F, Knip M. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B. Expert Rev Vaccines. 2018;17(12):1071–1083. doi: 10.1080/14760584.2018.1548281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1548281</ArticleId><ArticleId IdType="pubmed">30449209</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw N, Melchers WJ, Balk AH, de Jonge N, Galama JM. No evidence for persistent enterovirus infection in patients with end-stage idiopathic dilated cardiomyopathy. J Infect Dis. 1998;178(1):256–259. doi: 10.1086/517448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/517448</ArticleId><ArticleId IdType="pubmed">9652450</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco DR, Kottapalli SV, Breitwieser FP, et al. Deconvoluting virome-wide antibody epitope reactivity profiles. EBioMedicine. 2022;75:103747. doi: 10.1016/j.ebiom.2021.103747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103747</ArticleId><ArticleId IdType="pmc">PMC8688874</ArticleId><ArticleId IdType="pubmed">34922324</ArticleId></ArticleIdList></Reference><Reference><Citation>Sioofy-Khojine AB, Honkimaa A, Hyöty H. A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses. Diabet Med. 2020;37(11):1849–1853. doi: 10.1111/dme.14175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.14175</ArticleId><ArticleId IdType="pubmed">31705692</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>